Selenium Mood Randomized Trial: What the Evidence Says

Selenium Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed bi

3 min read · 543 wordsReviewed June 2026
From above of small white ellipse shaped pills of same size randomly placed on bright yellow background - Evidence evidence guide for selenium mood randomized trial
Photo by www.kaboompics.com on Pexels · Pexels License

Quick Answer

Selenium Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public health sources, so conclusions should be framed as evidence aware guidance rather than medical advice.

Key Takeaways

  • 01This page is generated only from sources stored in the Migaku evidence knowledge base.
  • 02Current evidence mix: 1 narrative review, 1 preclinical study.
  • 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • 04This article is educational and does not replace care from a qualified clinician.

Selenium Mood Randomized Trial: What the Evidence Says

Quick Answer

Selenium Mood Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

  • This page is generated only from sources stored in the Migaku evidence knowledge base.
  • Current evidence mix: 1 narrative review, 1 preclinical study.
  • Claims should be interpreted with the source type, study design, population, and publication date in mind.
  • This article is educational and does not replace care from a qualified clinician.

Evidence Map

Source Evidence type Level Date Identifier
Plant-derived nutritional components in thyroid disease-related neuropsychiatric disorders: mechanistic insights and advances narrative review 3 2026-02-19 10.3389/fnut.2026.1695902
Beyond levothyroxine: a narrative review of adjunctive management strategies for Hashimoto’s thyroiditis preclinical study 4 2026-04-24 10.21037/gs-2025-1-554

What The Sources Report

  • Both thyroidectomy and radioactive iodine therapy frequently induce iatrogenic hypothyroidism, leading to persistent cognitive slowing, low mood, and fatigue, while the psychological burden of cancer increases the risk of anxiety and depressive symptoms. [Zhang Zihan (2026); evidence level 3]
  • Nutritional factors such as iodine and selenium have been investigated in relation to thyroid cancer risk, but epidemiological findings remain inconsistent, and the influence of cruciferous vegetables on thyroid function or thyroid cancer risk is similarly controversial, with current evidence still limited. [Zhang Zihan (2026); evidence level 3]
  • It is associated with elevated anti-thyroid peroxidase antibodies (TPOAb) and often anti-thyroglobulin antibodies (TgAb). [Personius Lydia (2026); evidence level 4]
  • The incidence of HT has increased over recent decades and is higher with advancing age, in women, and in iodine-sufficient populations. [Personius Lydia (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For selenium mood randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

  • Zhang Zihan (2026). Plant-derived nutritional components in thyroid disease-related neuropsychiatric disorders: mechanistic insights and advances. DOI: 10.3389/fnut.2026.1695902. PMCID: PMC12960140. PMID: 41798846. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12960140/
  • Personius Lydia (2026). Beyond levothyroxine: a narrative review of adjunctive management strategies for Hashimoto’s thyroiditis. DOI: 10.21037/gs-2025-1-554. PMCID: PMC13184362. PMID: 42164686. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13184362/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.

FAQ

Frequently Asked Questions

M

Medically reviewed

Last reviewed June 28, 2026 by Migaku Evidence Review

Related content

← All GuidesSupplement Reference →